HE 106/2015 vp StV 27.11.2015 Suomen Lääkerinnakkaistuojat ry Asiantuntijalausunto

This procedure involves an expert opinion regarding the Finnish healthcare system, specifically focusing on medicine reimbursements, pharmacy fees, and the costs associated with medical treatments. It aims to evaluate how pharmaceutical pricing and patient contributions impact the accessibility of healthcare services. This affects patients relying on prescription drug reimbursements, pharmacies, wholesalers, and healthcare providers including doctors and dentists.